Showing results (1-10 of 175) with videos related to
Sort By:
Pageof 18
American Journal of Clinical Pathology|November 1, 1993
Epithelioid angiosarcoma arising in uterine leiomyomasG Tallini, F V Price, M L CarcangiuActa Pathologica Japonica|May 1, 1992
Oncocytic neoplasms of the thyroid glandG Tallini, M L Carcangiu, J RosaiThe American Journal of Pathology|March 10, 2001
Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosisG Garcia-Rostan, R L Camp, A Herrero, et al.Cancer Research|April 23, 1999
Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinomaG Garcia-Rostan, G Tallini, A Herrero, et al.The American Journal of Surgical Pathology|June 12, 1999
Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categoriesG Tallini, G Garcia-Rostan, A Herrero, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypesG Tallini, M Santoro, M Helie, et al.Cancer|May 12, 1998
CA 125 may not reflect disease status in patients with uterine serous carcinomaF V Price, S K Chambers, M L Carcangiu, et al.Gynecologic Oncology|December 1, 1993
Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC)F V Price, S K Chambers, M L Carcangiu, et al.Anatomic Pathology (Chicago, Ill. : Annual)|January 1, 1997
Uterine pathology in tamoxifen-treated patients with breast cancerM L CarcangiuPageof 18